G3BP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.165400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.317800E-01
Normal-vs-Stage2
7.453600E-01
Normal-vs-Stage3
2.291600E-01
Normal-vs-Stage4
1.668960E-01
Stage1-vs-Stage2
7.543800E-01
Stage1-vs-Stage3
2.474400E-02
Stage1-vs-Stage4
1.241020E-01
Stage2-vs-Stage3
1.336360E-01
Stage2-vs-Stage4
3.982300E-02
Stage3-vs-Stage4
3.113700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.286200E-01
Normal-vs-AfricanAmerican
5.118800E-01
Normal-vs-Asian
9.116400E-01
Caucasian-vs-AfricanAmerican
4.475800E-01
Caucasian-vs-Asian
3.902400E-01
AfricanAmerican-vs-Asian
2.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.573400E-01
Normal-vs-Female
6.615800E-01
Male-vs-Female
6.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.544200E-01
Normal-vs-Age(41-60Yrs)
4.302000E-01
Normal-vs-Age(61-80Yrs)
8.532200E-01
Normal-vs-Age(81-100Yrs)
7.383400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.972200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.546400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.958000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.759670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.194400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.934800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.834000E-01
Normal-vs-Daily Drinker
6.018400E-01
Normal-vs-Weekly Drinker
9.364800E-01
Normal-vs-Occasional Drinker
3.560200E-01
Normal-vs-Social Drinker
5.293200E-01
Non Drinker-vs-Daily Drinker
4.565200E-01
Non Drinker-vs-Weekly Drinker
9.344200E-01
Non Drinker-vs-Occasional Drinker
2.635900E-02
Non Drinker-vs-Social Drinker
1.354240E-01
Daily Drinker-vs-Weekly Drinker
5.140200E-01
Daily Drinker-vs-Occasional Drinker
9.279400E-03
Daily Drinker-vs-Social Drinker
6.056100E-02
Weekly Drinker-vs-Occasional Drinker
7.060100E-02
Weekly Drinker-vs-Social Drinker
2.099000E-01
Occasional Drinker-vs-Social Drinker
6.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.291790E-01
Normal-vs-Grade 2
3.450300E-02
Normal-vs-Grade 3
2.579800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.673600E-01
Grade 1-vs-Grade 3
7.775000E-01
Grade 1-vs-Grade 4
1.291790E-01
Grade 2-vs-Grade 3
6.040600E-01
Grade 2-vs-Grade 4
3.450300E-02
Grade 3-vs-Grade 4
2.579800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.874600E-01
Normal-vs-NonDiabetic
7.803200E-01
Diabetic-vs-NonDiabetic
4.043000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.466600E-01
Normal-vs-NoPancreatitis
7.899800E-01
Pancreatitis-vs-NoPancreatitis
2.885200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.534200E-01
Normal-vs-N1
7.436400E-01
N0-vs-N1
4.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.377200E-01
Normal-vs-TP53-NonMutant
6.021200E-01
TP53-Mutant-vs-TP53-NonMutant
8.806400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
